JPS63181771A - Catheter for bile duct - Google Patents
Catheter for bile ductInfo
- Publication number
- JPS63181771A JPS63181771A JP62012965A JP1296587A JPS63181771A JP S63181771 A JPS63181771 A JP S63181771A JP 62012965 A JP62012965 A JP 62012965A JP 1296587 A JP1296587 A JP 1296587A JP S63181771 A JPS63181771 A JP S63181771A
- Authority
- JP
- Japan
- Prior art keywords
- tube
- catheter
- slit
- check valve
- opens
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000000013 bile duct Anatomy 0.000 title description 9
- 238000002513 implantation Methods 0.000 claims description 8
- 238000007920 subcutaneous administration Methods 0.000 claims description 8
- 238000004891 communication Methods 0.000 claims description 4
- 238000005192 partition Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 description 10
- 238000002347 injection Methods 0.000 description 10
- 239000002246 antineoplastic agent Substances 0.000 description 8
- 238000003780 insertion Methods 0.000 description 8
- 230000037431 insertion Effects 0.000 description 8
- 210000003736 gastrointestinal content Anatomy 0.000 description 7
- 238000004018 waxing Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 4
- 208000008599 Biliary fistula Diseases 0.000 description 3
- 210000000941 bile Anatomy 0.000 description 3
- 210000001198 duodenum Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 208000032544 Cicatrix Diseases 0.000 description 2
- 239000004809 Teflon Substances 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 230000000414 obstructive effect Effects 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 230000037387 scars Effects 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 239000004945 silicone rubber Substances 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 206010016717 Fistula Diseases 0.000 description 1
- 101000793686 Homo sapiens Azurocidin Proteins 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- IDCBOTIENDVCBQ-UHFFFAOYSA-N TEPP Chemical compound CCOP(=O)(OCC)OP(=O)(OCC)OCC IDCBOTIENDVCBQ-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 201000010312 acute cholangitis Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 238000002674 endoscopic surgery Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000010794 food waste Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000003228 intrahepatic bile duct Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- External Artificial Organs (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.
Description
【発明の詳細な説明】
(1)、産業上の利用分野
この発明は医療用カテーテル中胆道用カテーテルに関す
るものであり、より具体的には閉塞性黄痕に用いる留置
性の胆道内留置カテーテル、更に詳しくは体内埋設型あ
るいは体外露出型の留置可能な胆道用カテーテルに関す
るものである。DETAILED DESCRIPTION OF THE INVENTION (1) Industrial Application Field This invention relates to medical catheters and biliary catheters, and more specifically to indwelling intrabiliary catheters used for obstructive yellow scars; More specifically, the present invention relates to an indwellable biliary catheter that can be implanted in the body or exposed outside the body.
(2)、従来の技術
最近、根治や切除が不可能と判断される閉塞性黄痕に対
し、非観血的胆道内ろう術が手術の容易さ、侵襲の少な
さ、又は観血的胆道内ろう術と変わらない減黄効果があ
るため広く行なわれるようになった。(2), Conventional technology Recently, non-invasive biliary endostomy has been developed for obstructive yellow scars that are judged to be impossible to completely cure or remove. It has become widely practiced because it has the same yellow-reducing effect as endoscopic surgery.
従来、このような胆道内ろう術に用いるカテーテルとし
て種々のものが提案されているが、いずれのものもカテ
ーテルチューブの挿入先端側となる一端が開口し、該開
口部が脂性形成の主原因である腸管内容物の逆流を防止
可能な構造となっていなかった。Conventionally, various catheters have been proposed for use in such biliary endostomy, but all of them have an opening at one end, which is the insertion tip of the catheter tube, and this opening is the main cause of oily formation. It did not have a structure that could prevent the regurgitation of certain intestinal contents.
(3)、発明が解決しようとする問題点従来の胆道内ろ
う化カテーテルは、前記のように一端開口部が逆流防止
機能をもたないため、カテーテルを留置後1〜2ケ月た
つと腸管内容物が逆流し、カテーテルチューブが脂性に
よる閉塞をきたすことが多くなって、急性胆管炎や胆膿
瘍などの重篤な合併症を併発する危惧がある、といった
問題点があった。(3) Problems to be Solved by the Invention In the conventional biliary fistula catheter, the opening at one end does not have a backflow prevention function as described above, so that the intestinal contents may be lost 1 to 2 months after the catheter is indwelled. Problems include the possibility that objects may flow backwards and the catheter tube becomes obstructed by oily substances, leading to serious complications such as acute cholangitis and bile abscess.
そこで、この発明は前記従来のカテーテルがもつ問題点
を排除すべく、脂性形成の主原因である腸管内容物のカ
テーテルチューブへの逆流を防止できるようにすること
を技術的課題とする。Therefore, in order to eliminate the problems associated with the conventional catheters, the technical object of the present invention is to prevent intestinal contents from flowing back into the catheter tube, which is the main cause of oily formation.
(4)、問題点を解決するための手段
前記技術的課題を達成するため、この発明の第1発明と
しての胆道用カテーテルは、一端にガイドワイヤーが通
過可能で、かつ内圧によって開くスリット伏動止弁を有
するカテーテルチューブ、又は一端にガイドワイヤーの
通過により開く放射状の切れ目と、該一端近くに内圧に
よって開くスリット状逆止弁とを有するカテーテルチュ
ーブを具えたことを特徴とし、第2発明としての胆道用
カテーテルは、一端にガイドワイヤーが通過可能で、か
つ内圧によって開くスリット状逆止弁を有するカテーテ
ルチューブ、又は一端にガイドワイヤーの通過により開
く放射状の切れ目と、該一端近くに内圧によって開くス
リット状逆止弁とを有するカテーテルチューブを具え、
前記カテーテルチューブの軸方向内部が仕切壁によって
一端から他端にわたり2つの流路に形成されており、前
記一方の流路は一端が閉塞部材で閉塞されているととも
に、他端が皮下埋め込み用のリザーバーと連通して着脱
可能に接続され、かつ他方の流路は一端が開口されてい
るとともに、他端が前記リザーバーとスリット状逆止弁
を介し連通して接続された皮下埋め込み用のポンプと連
通して着脱可能に接続されていることを特徴とする。(4) Means for Solving the Problems In order to achieve the above-mentioned technical problem, a biliary catheter according to the first aspect of the present invention has a slit at one end through which a guide wire can pass, and a slit that opens by internal pressure. A second invention characterized by comprising a catheter tube having a stop valve, or a catheter tube having a radial cut at one end that opens when a guide wire passes therethrough, and a slit-like check valve that opens by internal pressure near the one end. A biliary catheter includes a catheter tube having a slit-like check valve at one end through which a guide wire can pass and which opens by internal pressure, or a radial slit at one end that opens by passage of the guide wire, and a catheter tube that opens by internal pressure near the one end. a catheter tube having a slit-like check valve;
The inside of the catheter tube in the axial direction is formed into two channels from one end to the other by a partition wall, and one end of the one channel is closed with a closing member, and the other end is a channel for subcutaneous implantation. A pump for subcutaneous implantation, which is connected to a reservoir in a removable manner and communicates with the reservoir, and the other flow path is open at one end, and the other end is connected to the reservoir through a slit-shaped check valve. It is characterized by being connected in communication and detachably.
(5)、作 用
前記のような技術的手段の採用により、腸管内容物のカ
テーテルチューブへの逆流がカチーチルチューブの一端
又は一端近くに設けたスリット状逆止弁によって防止さ
れ、従来のような脂性によるカテーテルチューブの閉塞
はなくなる。(5) Effect: By adopting the technical means described above, the backflow of intestinal contents into the catheter tube is prevented by the slit-shaped check valve provided at or near one end of the catheter tube, which prevents the intestinal contents from flowing back into the catheter tube. The catheter tube is no longer obstructed by oily substances.
(6)、実施例
第1図は胆道内ろう化カテーテルに実施した第1実施例
を示し、該胆道内ろう化カテーテル1は生体異常性の少
ないシリコーンゴムからなる所定長さのカテーテルチュ
ーブ2゜3を具えている。チューブ2の一端には図示し
ないガイドワイヤーが通過可能で、かつ内圧によって開
くスリット状逆止弁5が装着されている。逆止弁5は2
枚のシリコーンゴムシート6.7が重ね合せられたうえ
、両側縁が接着されており、かつシート6.7の先端部
分が扁平につぶされて、このつぶされた部分の先端縁が
接着されないでスリット8に形成されている。(6), Embodiment FIG. 1 shows a first embodiment implemented in a biliary waxing catheter, and the biliary waxing catheter 1 has a catheter tube 2° of a predetermined length made of silicone rubber with little biological abnormality. It has 3. A slit-shaped check valve 5 is attached to one end of the tube 2, through which a guide wire (not shown) can pass, and which is opened by internal pressure. Check valve 5 is 2
Two silicone rubber sheets 6.7 are stacked one on top of the other, and both edges are glued together, and the tip of the sheet 6.7 is flattened so that the tip of the crushed portion is not glued. It is formed in the slit 8.
10はテフロン製の中空状コネクターで、該コネクター
10を介してチューブ2の他端とチューブ3の一端が連
通して着脱可能に接続されるようになっている。チュー
ブ3の他端には皮下埋め込み用のりザーバ−12が連通
して接続されている。リザーバー12はテトロンメツシ
ュ入り底部13に注射針が貫通するのを防ぐステンレス
板からなる針受は部14を、針受は部14と対向する側
に注射針が刺突可能で、かつ刺突した注射針が抜かれる
と、刺突により形成される穴が自然に閉塞される自己閉
塞性のよい弾性材料からなるドーム状の針さし部15を
もっており、針さし部15の下部周縁が底部13上にチ
ューブ3の他端を介して接着されることによって構成さ
れる。逆止弁5のあるチューブ2の一端側は前記したも
のに限定されず、第2図に示すような構造、すなわち、
チューブ2の一端がほぼ半球状に閉じられ、この閉塞端
にガイドワイヤーの通過により開く放射状の切れ口20
が設けられ、かつチューブ2の一端近くに内圧によって
開くスリット状逆止弁21が設けられた構造としてもよ
い。Reference numeral 10 denotes a hollow connector made of Teflon, through which the other end of the tube 2 and one end of the tube 3 communicate and are detachably connected. A glue reservoir 12 for subcutaneous implantation is connected to the other end of the tube 3 in communication. The reservoir 12 has a needle receiver part 14 made of a stainless steel plate that prevents the injection needle from penetrating the bottom part 13 containing the Tetron mesh, and a needle receiver that allows the injection needle to penetrate into the side opposite to the part 14. It has a dome-shaped needle insertion part 15 made of an elastic material with good self-closing properties that naturally closes the hole formed by the puncture when the injection needle is pulled out, and the lower peripheral edge of the needle insertion part 15 is It is constructed by being glued onto the bottom part 13 via the other end of the tube 3. The one end side of the tube 2 where the check valve 5 is located is not limited to the one described above, but has a structure as shown in FIG. 2, that is,
One end of the tube 2 is closed in a substantially hemispherical shape, and a radial cut 20 is formed at this closed end, which opens when the guide wire passes through.
It is also possible to have a structure in which a slit-shaped check valve 21 that opens due to internal pressure is provided near one end of the tube 2.
切れ口20の数は適宜の数、選択することが可能で、図
示のものに限定されないことは言う迄もない。It goes without saying that the number of cuts 20 can be selected as appropriate and is not limited to the number shown.
次に、第1図の胆道内ろう化カテーテル1を用いた非観
血的胆道内ろう術の一例を第3図に基いて説明する。Next, an example of a non-invasive biliary fistula using the biliary fistula catheter 1 shown in FIG. 1 will be described with reference to FIG. 3.
第3図においてイは肝臓、口は膵臓、ハは胆のう、二は
十二指腸、ホはファーター氏乳頭、へは皮膚をそれぞれ
示すが、これら内臓の諸器管の位置はその関係位置を示
すに止まっていることを了承されたい。In Figure 3, A indicates the liver, the mouth indicates the pancreas, C indicates the gallbladder, II indicates the duodenum, E indicates the papilla of Vater, and H indicates the skin, but the positions of these internal organs are merely to show their relative positions. Please acknowledge that
まず、セルジンゴー法で右側の肝内胆管を内外二重針2
3a、 23bからなる穿刺器23で穿刺する(第3図
A)。次に、穿刺器23の内針23bを抜き、残った外
針23bの中にガイドワイヤー25をその先端がファー
ター氏乳頭ホを越えるまで挿入する(第3図B)。ガイ
ドワイヤー25の挿入を終えたら、ガイドワイヤー25
をそのまま残して外針23aを抜去し、抜去した後、必
要により図示しないダイレータをガイドワイヤー25に
沿って挿入し、ろう孔を拡張する。First, the right intrahepatic bile duct was inserted using the Seldingo method with two internal and external double needles.
A puncture is performed using a puncture device 23 consisting of 3a and 23b (Fig. 3A). Next, the inner needle 23b of the puncture device 23 is removed, and the guide wire 25 is inserted into the remaining outer needle 23b until its tip passes beyond Vater's nipple (FIG. 3B). After inserting the guide wire 25,
The outer needle 23a is removed while leaving the outer needle 23a as it is, and after removal, a dilator (not shown) is inserted along the guide wire 25 if necessary to dilate the fistula.
次に、ダイレータを挿入したときはそれを抜去した後、
チューブ2を逆止弁5側を先頭に、ガイドワイヤー25
が逆止弁5のスリット8を経てその内部を通過するよう
に目的の部位まで挿入し、留置する。この際、チューブ
2は術前にレントゲン写真を見て、患者の胆管の長さに
合わせてその長さを見極めておき、必要により所定の長
さに切断される。また、必要とされる目的の部位に位置
することとなるチューブ2には術前に丸のみ鉗子などで
透孔26が穿設される(第3図C)。Next, when you insert the dilator, after removing it,
Place the tube 2 with the check valve 5 side at the top and guide wire 25.
The check valve 5 is inserted through the slit 8 of the check valve 5 to the target site, and left in place. At this time, the length of the tube 2 is determined based on the length of the patient's bile duct by looking at an X-ray photograph before the surgery, and the tube 2 is cut to a predetermined length if necessary. In addition, a through hole 26 is made in the tube 2, which will be located at the desired target site, using circular forceps or the like before the surgery (FIG. 3C).
次に、ガイドワイヤー25を抜去した後、リザーバー1
2のあるチューブ3の一端側を所定の長さに切断し、皮
下をはわせたうえ、その一端をコネクター10を介して
チューブ2の他端に接続する。この接続の後、リザーバ
ー12の底部13を筋膜に縫いつけて固定し、その後に
表皮を縫合すると、手術は終了する。(第3図D)。Next, after removing the guide wire 25, the reservoir 1
One end of the tube 3 with 2 is cut to a predetermined length, inserted under the skin, and the one end is connected to the other end of the tube 2 via the connector 10. After this connection, the bottom 13 of the reservoir 12 is sewn and fixed to the fascia, and then the epidermis is sutured to complete the surgery. (Figure 3D).
前記のようにして体内に埋設されてカテーテル1におけ
るリザーバー12内には必要に応じて25〜27Gの注
射針が針さし部15に刺突されることにより、抗ガン剤
、生理的食塩水、造影剤等が注入される。この注入され
た抗ガン剤等はチューブ3,2をそれぞれ通過し、逆止
弁5のスリット8を通過して十二指腸二へ、また前記透
孔26を通過して胆管とチューブ2間の閉塞された位置
より上流側の胆管内へ流れる。The reservoir 12 of the catheter 1 embedded in the body as described above is filled with anti-cancer drugs and physiological saline by inserting a 25-27G injection needle into the needle insertion part 15 as needed. , a contrast agent, etc. are injected. The injected anti-cancer agent passes through the tubes 3 and 2, passes through the slit 8 of the check valve 5, enters the duodenum 2, and passes through the through hole 26, leading to the blockage between the bile duct and the tube 2. Flows into the bile duct upstream from the position where the bile duct is located.
一方、腸管内容物が胆管内に、すなわち胆管内に配した
カテーテルチューブ2内に逆流しようとしても、該逆流
はチューブ2の一端に設けた逆止弁5によって防止され
、チューブ2内に脂性や食物残滓が入り込んでチューブ
2を閉塞するようなことがない。On the other hand, even if the intestinal contents try to flow back into the bile duct, that is, into the catheter tube 2 placed in the bile duct, the back flow is prevented by the check valve 5 provided at one end of the tube 2, and the inside of the tube 2 is filled with oil and other substances. There is no possibility that food residue will enter and block the tube 2.
第4図は胆道外ろう化カテーテルに実施した第2実施例
を示し、該胆道外ろう化カテーテル31において第1実
施例と相違するところを説明すると、チューブ3にはチ
ューブ固定用カフ32が接着剤でチューブ3の適宜の位
置に固定できるように摺動自在に嵌挿されている。カフ
32により固定されて体外に露出することとなるチュー
ブ3の他端には針さし部としてのインジェクションサイ
ト33を着脱可能に結合し得るような注入用ルアーコネ
クター35と、バンド36により連結されてインジェク
ションサイト33を使用しないとき、コネクター35に
装着されるキャップ37が設けられている。この実施例
においては抗ガン剤等が体外においてコネクター35に
挿入される注射器から、又はコネクター35に結合され
たインジェクション33に刺突される注射針から注入さ
れることになる。FIG. 4 shows a second embodiment implemented on an external biliary waxing catheter, and to explain the differences from the first embodiment in the external biliary waxing catheter 31, a tube fixing cuff 32 is bonded to the tube 3. The tube 3 is slidably inserted so that it can be fixed at an appropriate position in the tube 3 with an adhesive. The other end of the tube 3, which is fixed by the cuff 32 and exposed outside the body, is connected by a band 36 to an injection luer connector 35 to which an injection site 33 as a needle insertion part can be removably connected. A cap 37 is provided that is attached to the connector 35 when the injection site 33 is not in use. In this embodiment, an anticancer agent or the like is injected outside the body from a syringe inserted into the connector 35 or from an injection needle inserted into the injection 33 connected to the connector 35.
第5図は胆道内ろう化カテーテルに実施した第3実施例
を示す。この胆道内ろう化カテーテル41のチューブ4
2.43の軸方向内部は仕切壁44.45によってそれ
ぞれ一端から他端にわたり2つの流路46.47.48
.49に形成されており、かつ流路46.47のあるチ
ューブ42の他端と、流路48.49のあるチューブ4
3の一端とは流路に嵌合する形に形成されたコネクター
51.52により連通して接続されている。チューブ4
2の流路46の一端は閉塞部材53で閉塞され、またチ
ューブ43の流路48の他端は皮下埋め込み用のりザー
バ−55と連通して接続されている。リザーバー55に
おいて、56は第1実施例と同様な針受は部、57は針
さし部である。リザーバー55には固定部58により固
定された短管60を介して連通した皮下埋め込み用のポ
ンプ61が、チューブ43の流路49の他端と連通して
設けられている。ポンプ61はリザーバーとしての機能
も併せ有し、そのため、前記と同様な針受は部62と針
さし部63をもっている。短管60のポンプ61内に突
出した端部には第1実施例の逆止弁5と同様の逆止弁6
5が設けられている。尚、66はリザーバー55及びポ
ンプ61が屈曲したりしないように支持するためのテフ
ロンメツシュ入り支持底部である。FIG. 5 shows a third embodiment implemented in an intrabiliary waxing catheter. Tube 4 of this intrabiliary waxing catheter 41
The axial interior of 2.43 has two flow passages 46, 47, 48 extending from one end to the other by partition walls 44, 45, respectively.
.. 49 and the other end of the tube 42 with the passage 46.47 and the other end of the tube 42 with the passage 48.49.
It is connected to one end of 3 by means of connectors 51 and 52 formed to fit into the flow path. tube 4
One end of the flow path 46 of the tube 43 is closed with a closing member 53, and the other end of the flow path 48 of the tube 43 is connected in communication with a glue reservoir 55 for subcutaneous implantation. In the reservoir 55, 56 is a needle receiver part similar to that of the first embodiment, and 57 is a needle insertion part. A pump 61 for subcutaneous implantation is provided in the reservoir 55 and communicated with the other end of the channel 49 of the tube 43 via a short tube 60 fixed by the fixing part 58 . The pump 61 also has the function of a reservoir, and therefore the same needle receiver as described above has a section 62 and a needle insertion section 63. A check valve 6 similar to the check valve 5 of the first embodiment is provided at the end of the short pipe 60 that protrudes into the pump 61.
5 is provided. Incidentally, 66 is a supporting bottom part containing Teflon mesh for supporting the reservoir 55 and pump 61 so that they do not bend.
この第3実施例のカテーテル41の場合、チユーブ42
の流路46側に前記したような透孔が穿設されるように
なる。そして、使用に際し、リザーバー55内には必要
に応じて前記と同様に抗ガン剤等が注入され、この注入
された抗ガン剤等は、チューブ43.42の流路48.
46を通過し、前記透孔から流れるとともに、リザーバ
ー55から逆止弁65のスリットを通過して入り込むポ
ンプ61から、ポンプ61を押圧することにより、チュ
ーブ43.42の流路49.47を通過し、逆止弁5の
スリット8を通過して流れる。この際、抗ガン剤等を主
に透孔から流したいときはポンプ61を押圧してつぶす
ようにし、逆止弁65のスリットから抗ガン剤等がポン
プ61側に流れないようにする。In the case of the catheter 41 of this third embodiment, the tube 42
A through hole as described above is formed on the flow path 46 side. In use, an anticancer agent or the like is injected into the reservoir 55 as necessary in the same manner as described above, and the injected anticancer agent or the like is transferred to the channel 48 of the tube 43, 42.
46 and flows from the through hole, and from the pump 61 entering from the reservoir 55 through the slit of the check valve 65, by pressing the pump 61, it passes through the channel 49.47 of the tube 43.42. and flows through the slit 8 of the check valve 5. At this time, when it is desired that the anti-cancer agent etc. mainly flow through the through hole, the pump 61 is pressed and crushed to prevent the anti-cancer agent etc. from flowing to the pump 61 side from the slit of the check valve 65.
また、前記透孔を経てチューブ42の流路46に入る胆
管内の胆汁は、チューブ43の流路48を経てリザーバ
ー55に貯留された後、逆止弁65のスリットを通過し
てポンプ61に入り込むこととなるので、ポンプ61を
押圧することにより、逆止弁5のスリット8から十二指
腸二へ流す。Further, the bile in the bile duct that enters the flow path 46 of the tube 42 through the through hole is stored in the reservoir 55 through the flow path 48 of the tube 43, and then passes through the slit of the check valve 65 to be pumped into the pump 61. Therefore, by pressing the pump 61, the fluid flows from the slit 8 of the check valve 5 to the duodenum 2.
この実施例において、針さし部63に注射針を刺突して
抗ガン剤等をポンプ61内に注入するような使用も可能
であることは言う迄もない。It goes without saying that this embodiment can also be used to inject an anticancer agent or the like into the pump 61 by inserting an injection needle into the needle insertion portion 63.
(7)、発明の効果
この発明は前記のようであって、カテーテルチューブの
一端又は一端近くに設けたスリット状逆止弁により、腸
管内容物のカテーテルチューブへの逆流を確実に防止す
ることが可能となるから、脂性によるカテーテルチュー
ブの閉塞をなくすことができ、したがって従来危惧して
いた合併症の併発もなくなり、カテーテルの極めて安全
な留置を長期にわたって維持することができる。また、
カテーテルチューブを2つの流路に形成した第2発明に
おいては、胆汁の吸収、かつ胆管とチューブ間の閉塞さ
れた位置より下流側への排出が併せてできるという優れ
た効果が期待できる。(7) Effects of the Invention This invention is as described above, and the slit-shaped check valve provided at or near one end of the catheter tube reliably prevents intestinal contents from flowing back into the catheter tube. This makes it possible to eliminate occlusion of the catheter tube due to oil, thereby eliminating complications that were previously feared, and making it possible to maintain extremely safe indwelling of the catheter for a long period of time. Also,
In the second aspect of the invention in which the catheter tube is formed into two channels, an excellent effect can be expected in that bile can be absorbed and discharged downstream from the occluded position between the bile duct and the tube.
第1図はこの発明の第1実施例を示し、(A)はカテー
テルチューブの一部を省略した縦断正面図、(B)はス
リット状逆止弁のあるチューブの部分拡大斜視図、第2
図は同上のチューブの変形例を示し、(A)はスリット
状逆止弁のあるチューブの部分正面図、(B)は(A)
の部分拡大斜視図、第3図(A)〜(D)は第1実施例
のカテーテルの使用例を示す概略図、第4図は第2実施
例を示すカテーテルチューブの一部を省略した一部縦断
の正面図、第5図は第3実施例を示すカテーテルチュー
ブの一部を省略した縦断正面図である。
1.31.41・・・カテーテル
2 、3.42.43・・・カテーテルチューブ5.2
1.63・・・スリット状逆止弁8・・・スリット
10・・・コネクター12.55・・・リザー
バー 13・・・底 部14.56.62・・・
針受は部 15,57,63・・・針さし部20・
・・切れ目 25・・・ガイドワイヤー−1
5=FIG. 1 shows a first embodiment of the present invention, in which (A) is a longitudinal sectional front view with a part of the catheter tube omitted, (B) is a partially enlarged perspective view of the tube with a slit-shaped check valve, and FIG.
The figures show a modification of the same tube as above, (A) is a partial front view of the tube with a slit check valve, (B) is (A)
3(A) to 3(D) are schematic diagrams showing an example of the use of the catheter of the first embodiment, and FIG. 4 is a partial enlarged perspective view of the catheter tube of the second embodiment. FIG. 5 is a longitudinal sectional front view with a part of the catheter tube omitted, showing the third embodiment. 1.31.41...catheter 2, 3.42.43...catheter tube 5.2
1.63...Slit-shaped check valve 8...Slit
10... Connector 12.55... Reservoir 13... Bottom part 14.56.62...
Needle guard is part 15, 57, 63...needle insert part 20.
... Cut 25 ... Guide wire -1
5 =
Claims (1)
って開くスリット状逆止弁を有するカテーテルチューブ
、又は一端にガイドワイヤーの通過により開く放射状の
切れ目と、該一端近くに内圧によって開くスリット状逆
止弁とを有するカテーテルチューブを具えたことを特徴
とする胆道用カテーテル。 2、一端にガイドワイヤーが通過可能で、かつ内圧によ
って開くスリット状逆止弁を有するカテーテルチューブ
、又は一端にガイドワイヤーの通過により開く放射状の
切れ目と、該一端近くに内圧によって開くスリット状逆
止弁とを有するカテーテルチューブを具え、前記カテー
テルチューブの他端に皮下埋め込み用のリザーバーが連
通して着脱可能に接続されている特許請求の範囲第1項
に記載の胆道用カテーテル。 3、一端にガイドワイヤーが通過可能で、かつ内圧によ
って開くスリット状逆止弁を有するカテーテルチューブ
、又は一端にガイドワイヤーの通過により開く放射状の
切れ目と、該一端近くに内圧によって開くスリット状逆
止弁とを有するカテーテルチューブを具え、前記カテー
テルチューブの軸方向内部が仕切壁によって一端から他
端にわたり2つの流路に形成されており、前記一方の流
路は一端が閉塞部材で閉塞されているとともに、他端が
皮下埋め込み用のリザーバーと連通して着脱可能に接続
され、かつ他方の流路は一端が開口されているとともに
、他端が前記リザーバーとスリット状逆止弁を介し連通
して接続された皮下埋め込み用のポンプと連通して着脱
可能に接続されていることを特徴とする胆道用カテーテ
ル。[Scope of Claims] 1. A catheter tube having a slit-like check valve at one end through which a guide wire can pass and which opens due to internal pressure, or a radial cut at one end that opens when the guide wire passes through, and an internal pressure valve near the one end. A biliary catheter, comprising a catheter tube having a slit-like check valve that opens by. 2. A catheter tube with a slit-shaped check valve at one end through which a guide wire can pass and which opens by internal pressure, or a radial cut at one end that opens by passage of the guide wire, and a slit-shaped check valve near the one end that opens by internal pressure. The biliary catheter according to claim 1, comprising a catheter tube having a valve, and a reservoir for subcutaneous implantation communicating with and detachably connected to the other end of the catheter tube. 3. A catheter tube with a slit-shaped check valve at one end through which a guide wire can pass and which opens by internal pressure, or a radial cut at one end that opens by passage of the guide wire, and a slit-shaped check valve near the one end that opens by internal pressure. a catheter tube having a valve, the axial interior of the catheter tube is formed into two flow paths from one end to the other end by a partition wall, and one end of the one flow path is closed with a closing member. In addition, the other end communicates with and is removably connected to a reservoir for subcutaneous implantation, and one end of the other flow path is open, and the other end communicates with the reservoir through a slit-shaped check valve. A biliary catheter characterized in that the biliary catheter is detachably connected in communication with a pump for subcutaneous implantation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62012965A JPS63181771A (en) | 1987-01-21 | 1987-01-21 | Catheter for bile duct |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62012965A JPS63181771A (en) | 1987-01-21 | 1987-01-21 | Catheter for bile duct |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS63181771A true JPS63181771A (en) | 1988-07-26 |
JPH0345660B2 JPH0345660B2 (en) | 1991-07-11 |
Family
ID=11819961
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62012965A Granted JPS63181771A (en) | 1987-01-21 | 1987-01-21 | Catheter for bile duct |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS63181771A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0237650U (en) * | 1988-09-06 | 1990-03-13 | ||
JPH02102659A (en) * | 1988-10-12 | 1990-04-16 | Nissho Corp | Plant-type thoracic duct and vein shunt |
JPH04314454A (en) * | 1991-04-12 | 1992-11-05 | Hanako Medical Kk | Drainage tube |
JP2003503163A (en) * | 1999-07-02 | 2003-01-28 | コロプラスト アクティーゼルスカブ | Access members and systems for bladder catheterization through artificial or natural conduits in users and methods of replacing such access members |
JP2006501015A (en) * | 2002-10-01 | 2006-01-12 | ポテンシア・メディカル・アーゲー | Implantable pump that operates hydraulic implants |
US11986586B2 (en) | 2021-09-17 | 2024-05-21 | Naoyuki Ishikita | Catheter for chest drainage and chest drainage system |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS563064A (en) * | 1979-06-22 | 1981-01-13 | Olympus Optical Co | Catheter |
JPS58141154A (en) * | 1982-01-20 | 1983-08-22 | キャセタ−・テクノロジ−・コ−ポレ−ション | Method and apparatus for carring out intravenous treatment |
JPS59177065A (en) * | 1983-03-18 | 1984-10-06 | カ−ル・アイグナ− | Implantable injection catethel |
-
1987
- 1987-01-21 JP JP62012965A patent/JPS63181771A/en active Granted
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS563064A (en) * | 1979-06-22 | 1981-01-13 | Olympus Optical Co | Catheter |
JPS58141154A (en) * | 1982-01-20 | 1983-08-22 | キャセタ−・テクノロジ−・コ−ポレ−ション | Method and apparatus for carring out intravenous treatment |
JPS59177065A (en) * | 1983-03-18 | 1984-10-06 | カ−ル・アイグナ− | Implantable injection catethel |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0237650U (en) * | 1988-09-06 | 1990-03-13 | ||
JPH0440683Y2 (en) * | 1988-09-06 | 1992-09-24 | ||
JPH02102659A (en) * | 1988-10-12 | 1990-04-16 | Nissho Corp | Plant-type thoracic duct and vein shunt |
JPH04314454A (en) * | 1991-04-12 | 1992-11-05 | Hanako Medical Kk | Drainage tube |
JP2003503163A (en) * | 1999-07-02 | 2003-01-28 | コロプラスト アクティーゼルスカブ | Access members and systems for bladder catheterization through artificial or natural conduits in users and methods of replacing such access members |
JP2006501015A (en) * | 2002-10-01 | 2006-01-12 | ポテンシア・メディカル・アーゲー | Implantable pump that operates hydraulic implants |
JP4733389B2 (en) * | 2002-10-01 | 2011-07-27 | プロステシカ・アーゲー | Implantable pump that operates hydraulic implants |
US11986586B2 (en) | 2021-09-17 | 2024-05-21 | Naoyuki Ishikita | Catheter for chest drainage and chest drainage system |
Also Published As
Publication number | Publication date |
---|---|
JPH0345660B2 (en) | 1991-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6074377A (en) | Method of installing vascular access device | |
US6398764B1 (en) | Subcutaneously implanted cannula and method for arterial access | |
EP0547463B1 (en) | Catheter introducer assembly | |
AU2001257388B2 (en) | Implantable hemodialysis access device | |
US5931829A (en) | Methods and systems for establishing vascular access | |
US9993633B2 (en) | Graft-catheter vascular access system | |
US4795426A (en) | Catheter introducing device and method of placing catheter | |
EP0366814B1 (en) | Subcutaneously implanted catheter assembly | |
US7927325B2 (en) | Implantable pump connector for catheter attachment | |
US5944688A (en) | Implantable hemodialysis access port assembly | |
US5833662A (en) | Hemostasis cannula system | |
US20050209573A1 (en) | Method and apparatus for percutaneously accessing a pressure activated implanted port | |
WO1997012643A1 (en) | Subcutaneously implanted cannula and method for arterial access | |
US20040097903A1 (en) | Removable catheter hub | |
EP0996481A1 (en) | Method and apparatus for percutaneously accessing an implanted port | |
JPH0318903B2 (en) | ||
JP2005177482A (en) | Flexible injection port | |
AU2001257388A1 (en) | Implantable hemodialysis access device | |
CA2577614A1 (en) | Implantable medical site | |
US5147318A (en) | Valved arterial catheter | |
JPS63181771A (en) | Catheter for bile duct | |
JP4480919B2 (en) | Abdominal-venous shunt catheter | |
US8708956B2 (en) | Multi-lumen catheter with protected tip | |
JP2007007042A (en) | Multi-guide hole catheter, multi-guide hole catheter assembly , and method for operating the assembly | |
WO2018101847A1 (en) | Dialysis catheter assembly |